Article Information
History
- July 7, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Sinead Gaubert1,2,*,
- Pilar Garces3,
- Jörg Hipp3,
- Ricardo Bruña4,5,
- Maria Eugenia Lopéz5,
- Fernando Maestu5,
- Delshad Vaghari6,
- Richard Henson7,8,
- Claire Paquet1,2 and
- Denis Engemann3
- 1Université Paris Cité, Inserm UMRS 1144 Therapeutic Optimization in Neuropsychopharmacology, Paris, France
- 2Cognitive Neurology Center, GHU.Nord APHP Hôpital Lariboisière Fernand Widal, Paris, France
- 3Roche Pharma Research and Early Development, Neuroscience and Rare Diseases, Roche Innovation Center Basel, F. Hoffmann–La Roche Ltd., Basel, Switzerland
- 4Center for Cognitive and Computational Neuroscience, Complutense University of Madrid, 28223, Madrid, Spain
- 5Department of Experimental Psychology, Cognitive Processes and Speech Therapy, Complutense University of Madrid, Madrid, Spain
- 6Department of Psychology, University of Cambridge, UK
- 7MRC Cognition and Brain Sciences Unit, University of Cambridge, CB2 7EF, UK
- 8Department of Psychiatry, University of Cambridge, UK
- ↵*corresponding author: Sinead Gaubert, E-mail: sinead.gaubert{at}aphp.fr